A multicenter, open-label, phase 1 study evaluating the safety and tolerability of pegaspargase in combination with gemcitabine in advanced metastatic solid tumors and lymphoma

Mitesh J. Borad, Hani M. Babiker, Stephen Anthony, Monica Mita, Aby Buchbinder, Taha Keilani, Jean Grem

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'A multicenter, open-label, phase 1 study evaluating the safety and tolerability of pegaspargase in combination with gemcitabine in advanced metastatic solid tumors and lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences